Scientific corner

Pyoderma gangrenosum associated with ulcerative colitis: A recalcitrant case responded to adalimumab with granulocyte and monocyte adsorption apheresis

Yuki Isami,Yuriko Kawase,Akari Kondo,Wataru Akita,Koji Yasuda,Takeshi Matsutani,Hiroshi Mitsui

J Dermatol. 2020 May;47(5):e213-e215. doi: 10.1111/1346-8138.15303. Epub 2020 Mar 11.

letter.

https://pubmed.ncbi.nlm.nih.gov/32162361/

Adalidumab / combination / Dermatology / diabetes / EIM / gma / Infliximab / intensive / Loss of response / Pyoderma gangrenosum / Refractory patients / ulcerative colitis /

Contact UsFor more information

Contact Us